Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan · Delayed Price · Currency is TWD 37.00
+0.10 (0.27%)
Feb 11, 2026, 1:30 PM CST
Nang Kuang Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 257.07 | 243.41 | 198.41 | 352 | 196.11 | 183.4 |
Depreciation & Amortization | 184.25 | 182.96 | 181.96 | 176.28 | 179.75 | 185.29 |
Loss (Gain) From Sale of Assets | 4.18 | -0.17 | -6.1 | 0.05 | 0.15 | - |
Loss (Gain) From Sale of Investments | 28.82 | 23.07 | 1.85 | -70.49 | 2.22 | 7.33 |
Provision & Write-off of Bad Debts | -0.1 | -2.67 | 78.83 | 2.14 | 1.97 | 0.27 |
Other Operating Activities | 22.41 | 27.53 | 2.43 | 4.54 | 44.65 | -4.84 |
Change in Accounts Receivable | -11.33 | -52.17 | -61.46 | -29.37 | 12.95 | 3.06 |
Change in Inventory | -81.44 | 75.44 | 71.53 | -130.21 | 80.13 | -189.06 |
Change in Accounts Payable | 66.88 | 43.77 | -87.53 | 30.33 | 36.01 | -38.37 |
Change in Unearned Revenue | 0.45 | -4.07 | -14.53 | 10.95 | 10.17 | 4.5 |
Change in Other Net Operating Assets | 7.85 | -70.67 | -22.78 | 22.97 | -7.47 | -0.57 |
Operating Cash Flow | 479.02 | 466.43 | 342.61 | 369.19 | 556.63 | 151.01 |
Operating Cash Flow Growth | 9.64% | 36.14% | -7.20% | -33.67% | 268.61% | -60.90% |
Capital Expenditures | -477.06 | -524.6 | -297.51 | -93.84 | -156.05 | -90.14 |
Sale of Property, Plant & Equipment | 0.11 | 16.01 | 6.53 | 0.24 | 0.05 | - |
Sale (Purchase) of Intangibles | -0.9 | -1.32 | -3.22 | -0.33 | -3.69 | -1.55 |
Investment in Securities | - | 135 | -33.75 | 1.78 | -129.2 | -25.21 |
Other Investing Activities | -0.26 | 2.51 | -1.55 | -17.7 | -2.59 | 4.89 |
Investing Cash Flow | -478.12 | -372.39 | -329.51 | -109.85 | -291.48 | -112.01 |
Short-Term Debt Issued | - | 2,220 | 2,520 | 2,810 | 2,475 | 3,113 |
Long-Term Debt Issued | - | 175.22 | - | - | - | 50 |
Total Debt Issued | 3,634 | 2,395 | 2,520 | 2,810 | 2,475 | 3,163 |
Short-Term Debt Repaid | - | -2,350 | -2,310 | -2,920 | -2,375 | -3,103 |
Long-Term Debt Repaid | - | -13.94 | -13.55 | -13.8 | -52.9 | -52.8 |
Total Debt Repaid | -3,446 | -2,364 | -2,324 | -2,934 | -2,428 | -3,156 |
Net Debt Issued (Repaid) | 188.46 | 31.28 | 196.45 | -123.8 | 47.1 | 7.2 |
Common Dividends Paid | -161.58 | -201.98 | -232.27 | -181.78 | -161.58 | -171.68 |
Other Financing Activities | 6 | -0.27 | 0.06 | 30.27 | - | - |
Financing Cash Flow | 32.88 | -170.97 | -35.77 | -275.31 | -114.48 | -164.48 |
Foreign Exchange Rate Adjustments | 0 | -0 | -0.06 | 0.06 | -0.01 | -0.01 |
Net Cash Flow | 33.78 | -76.93 | -22.73 | -15.92 | 150.66 | -125.49 |
Free Cash Flow | 1.96 | -58.17 | 45.1 | 275.35 | 400.58 | 60.87 |
Free Cash Flow Growth | -97.36% | - | -83.62% | -31.26% | 558.08% | -80.44% |
Free Cash Flow Margin | 0.09% | -2.64% | 2.10% | 14.19% | 22.50% | 3.47% |
Free Cash Flow Per Share | 0.02 | -0.57 | 0.45 | 2.72 | 3.96 | 0.60 |
Cash Interest Paid | 8.43 | 5.6 | 7.06 | 4.81 | 3.5 | 4.33 |
Cash Income Tax Paid | 34.24 | 33.88 | 83.07 | 44.65 | 16.14 | 53.52 |
Levered Free Cash Flow | -182.92 | -165.25 | 150.61 | 192.96 | 332.75 | 9.01 |
Unlevered Free Cash Flow | -177.61 | -161.79 | 155.1 | 195.98 | 334.96 | 11.7 |
Change in Working Capital | -17.6 | -7.7 | -114.77 | -95.34 | 131.79 | -220.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.